Canada's New MDEL Rules (In Force December 2026): What Importers and Distributors Must Do Now

Canada's Phase II amendments to the Medical Devices Regulations (SOR/2026-110) were published in the Canada Gazette, Part II on June 17, 2026 and come into force on December 14, 2026. From that date, foreign distributors no longer need their own Medical Device Establishment Licence (MDEL) if they sell through a Canadian importer that already holds one. In exchange, MDEL applicants and holders must provide a list of their suppliers, and the requirement to establish, implement and maintain documented procedures is now explicit in the regulations. Importers and distributors should reassess their licensing structure and upgrade their documented procedures and supplier records before the deadline.

Executive Summary

On June 17, 2026, Health Canada published the second phase of its modernization of the medical device establishment licensing framework in the Canada Gazette, Part II. The amendments, registered as SOR/2026-110, come into force on December 14, 2026, which is 180 days after publication.

Three changes matter most to anyone who imports or distributes medical devices in Canada:

1. Foreign distributors are released from the MDEL requirement when they sell through a Canadian importer that holds an MDEL.
2. Supplier lists become mandatory. MDEL applicants and holders must submit supplier information with their application and refresh it each year at the annual licence review.
3. Documented procedures are now an explicit regulatory obligation, replacing the previous reliance on an attestation that Health Canada found was often not matched by reality.

Health Canada has updated GUI-0016, FRM-0292, GUI-0064 and GUI-0079 to reflect these changes, and will replace the existing versions when the rules take effect in December 2026. The next six months are a compliance promotion window, not a grace period for non-compliance after the deadline. Companies should treat December 14, 2026 as a hard date and use the time now to close gaps.

Introduction

If your company imports or distributes medical devices in Canada, the rules that govern your establishment licence are about to change in a way that affects both your paperwork and your supply chain.

For years, the Medical Devices Regulations (MDR) required both a foreign distributor and its Canadian importer to hold a Medical Device Establishment Licence. Industry told Health Canada this was redundant, costly and out of step with other jurisdictions. Health Canada listened. At the same time, the agency wanted better visibility into who actually supplies devices to the Canadian market, and it wanted to fix a long-standing gap between what licence holders attested to and what inspectors found on site.

The result is a balanced set of amendments: less licensing burden in one place, more documentation discipline in another. MFLRC supports companies across medical device licensing and compliance, and this article explains what changed, who is affected, what you must do before December 14, 2026, and where the common compliance traps lie. All regulatory points below are drawn from the Canada Gazette, Part II text of SOR/2026-110 and Health Canada's Medical Devices Compliance Program bulletin of June 17, 2026.

What Changed: The Three Phase II Amendments

1. Foreign distributors no longer need their own MDEL

Under the previous rules, any person importing a device had to verify that the party they imported from held an MDEL. In practice, this meant every foreign distributor selling into Canada needed its own licence, even when its Canadian importer already held one. Health Canada agreed this created a redundancy and a barrier to competitiveness.

From December 14, 2026, the requirement for Canadian MDEL holders to import only from foreign distributors that themselves hold an MDEL is removed. Importantly, this relief is conditional and limited:

• It applies where the foreign distributor sells through a Canadian importer that holds an MDEL.
• Persons who import without an MDEL, such as retailers and health care facilities, must still ensure that the parties they import from hold an MDEL.

So the licence does not disappear from the supply chain. It shifts to the Canadian importer, who carries the licensing and accountability.

2. Supplier lists become mandatory

Health Canada has been collecting supplier information on a voluntary basis since February 2020. Because it was voluntary, most MDEL holders did not provide it, leaving the agency with only partial visibility into who supplies devices to the Canadian market and limited ability to trace a non-compliant device through the supply chain.

Phase II closes that gap. MDEL applicants must now provide supplier information as part of their application, and licence holders must update that information once a year at the annual licence review. Applications still being processed when the amendments come into force must submit supplier information before a licence can be issued.

This is the trade-off for releasing foreign distributors from the MDEL requirement. Health Canada keeps a clear line of sight on suppliers, including foreign distributors who will no longer hold a licence themselves.

3. Documented procedures are now an explicit requirement

Previously, MDEL applicants attested that they had certain documented procedures in place. Health Canada's inspections repeatedly found that these procedures were lacking, out of date, or poorly implemented despite the attestation.

The amendments make the requirement explicit in the regulations. Manufacturers, importers and distributors must each establish, implement and maintain documented procedures across their safety-management activities, including:

• maintaining distribution records;
• handling complaints and conducting recalls;
• for Class II, III and IV devices, the handling, storage, delivery, installation and servicing of the device and the taking of corrective action; and
• making mandatory problem reports and providing implant-related information on a timely basis.

Because the obligation is now explicit, Health Canada has reduced the number of attestations required during licensing (section 45 of the MDR was updated accordingly). The message is clear: the agency expects to see real, current, implemented procedures rather than a signed attestation.

Key Dates and Documents at a Glance

Who Is Affected and How

What You Must Do Before December 14, 2026

The six months between publication and the in-force date is a window to get ready, not a buffer for non-compliance afterward. A practical, sequenced plan:

1. Reassess your licensing structure. Map your supply chain and decide who needs to hold the MDEL. If you rely on foreign distributors who currently hold their own MDEL, confirm whether they will let it lapse and whether your Canadian importer's licence covers the chain.
2. Build or formalize your supplier list. Capture each supplier's identity and the devices they supply. Decide how you will keep it current for the annual licence review (the review is due before April 1 each year).
3. Audit your documented procedures. Compare what you actually do against the explicit requirements for distribution records, complaint handling, recalls, problem reporting, and (for Class II to IV) handling, storage, delivery, installation, servicing and corrective action.
4. Close SOP gaps. Update or write procedures so they are accurate, current, and demonstrably implemented, not just on paper.
5. Train your team. Make sure staff understand and follow the procedures, and that records prove it.
6. Read the updated guidance. Review the updated GUI-0016, FRM-0292, GUI-0064 and GUI-0079 when published, and align your processes to them.
7. Plan your annual review submission. Build supplier-information updates into your annual licence review workflow so the first post-amendment review goes smoothly.

Compliance Checklist

Use this checklist to gauge readiness. Each item should be answerable with a confident yes before December 14, 2026.

• We have mapped our full import and distribution supply chain.
• We have confirmed which entity will hold the MDEL after the rules change.
• Our foreign distributors are selling through a Canadian importer that holds a valid MDEL.
• We have a complete, current list of suppliers and the devices they supply.
• We have a process to update supplier information at each annual licence review.
• We have documented procedures for maintaining distribution records.
• We have documented procedures for complaint handling and recalls.
• For Class II to IV devices, we have procedures for handling, storage, delivery, installation, servicing and corrective action.
• We have documented procedures for mandatory problem reporting and implant information.
• All procedures are current, implemented, and supported by records.
• Staff are trained on the procedures and can demonstrate compliance.
• We have reviewed the updated GUI-0016, FRM-0292, GUI-0064 and GUI-0079.

Common Mistakes to Avoid

Assuming the MDEL simply disappears. The licence does not leave the supply chain. It concentrates on the Canadian importer, who now carries more accountability. Foreign distributors should not drop their licence without confirming the Canadian importer's MDEL is valid and covers the chain.

Treating supplier lists as a one-time task. Supplier information must be refreshed every year at the annual licence review. Build it into a recurring workflow rather than a single submission.

Relying on old attestations. The attestation model is being scaled back precisely because procedures were often missing or stale. Inspectors will expect to see real, implemented, current procedures.

Waiting until December. Writing and embedding documented procedures, training staff, and assembling supplier data take time. Companies that start in the autumn risk rushing or missing the deadline.

Forgetting retailers and health care facilities. Parties that import without an MDEL get no relief. They must still verify that the party they import from holds an MDEL.

Overlooking in-flight applications. If your MDEL application is still being processed when the rules come into force, you must submit supplier information before the licence can be issued.

How These Changes Fit Health Canada's Broader Direction

Phase II is the second step in a modernization effort Health Canada committed to in 2018 to 2019 and which was delayed by the COVID-19 pandemic. Phase I, published in the Canada Gazette, Part II on June 17, 2024 and in force December 14, 2024, strengthened compliance and enforcement oversight. Phase II shifts the focus to reducing burden, promoting innovation, enhancing competitiveness, and improving supply-chain transparency. Both phases appear in Health Canada's Forward Regulatory Plan and Regulatory Stock Review Plan, signalling that the agency intends to keep refining the framework.

The practical takeaway is that establishment licensing is becoming more risk-based and traceability-focused. Companies that build mature quality systems now will be better positioned for whatever comes next.

Frequently Asked Questions

When do the new MDEL rules take effect?

The amendments (SOR/2026-110) were published in the Canada Gazette, Part II on June 17, 2026 and come into force on December 14, 2026, which is 180 days after publication.

Do foreign distributors still need an MDEL in Canada?

Not if they sell through a Canadian importer that holds an MDEL. From December 14, 2026, Canadian MDEL holders are no longer required to import only from foreign distributors that hold their own MDEL. Retailers and health care facilities that import directly without an MDEL must still ensure the party they import from holds one.

What supplier information do MDEL holders have to provide?

Applicants must provide a list of the suppliers of the devices they import or distribute as part of their MDEL application, and holders must update that information once a year at the annual licence review. Applications still being processed when the rules take effect must submit supplier information before a licence is issued.

What documented procedures does an MDEL holder need?

Manufacturers, importers and distributors must each establish, implement and maintain documented procedures covering distribution records, complaint handling and recalls, mandatory problem reporting, and, for Class II to IV devices, the handling, storage, delivery, installation and servicing of the device and the taking of corrective action.

Is the attestation requirement going away?

The number of attestations required during licensing has been reduced because documented procedures are now an explicit regulatory requirement. Section 45 of the MDR was updated to reflect this. The expectation is real, implemented procedures rather than a signed attestation.

What is GUI-0016?

GUI-0016 is Health Canada's Guidance on Medical Device Establishment Licensing. It explains how to apply for, maintain, amend, cancel and reinstate an MDEL. It has been updated to reflect Phase II and the updated version will replace the current one when the rules take effect in December 2026.

Does this change my annual licence review?

Yes. The annual licence review (due before April 1 each year) now includes updating your supplier information. Build this into your review workflow.

How MFLRC Can Help

MF License & Regulatory Consultants (MFLRC) helps medical device importers, distributors and manufacturers prepare for the December 14, 2026 deadline with practical, defensible deliverables rather than generic checklists. Our regulatory affairs, licensing and import/export team can position the right entity as the licence holder and prepare a complete, compliant submission.

• MDEL application and amendment support to position the right entity as the licence holder and prepare a complete, compliant submission.
• Documented procedure (SOP) development for distribution records, complaint handling, recalls, problem reporting, and Class II to IV handling, storage, servicing and corrective action.
• Supplier qualification and supplier-list programs that satisfy the new submission and annual-update requirements.
• Gap assessments and inspection-readiness reviews mapped directly to the Phase II requirements and the updated GUI-0016, GUI-0064 and GUI-0079.
• Quality management system builds and audits so your procedures are not just written but implemented and evidenced.

Our audit and inspection-readiness services and quality assurance support help you turn the new rules into a stronger quality system. Our senior-led team brings deep Canadian regulatory expertise across medical devices and adjacent regulated sectors, with cross-border capability for companies entering the Canadian market.

Need help getting ready for the new MDEL rules? Contact MFLRC for expert guidance tailored to your business and supply chain.

Conclusion

Phase II of Health Canada's MDEL modernization is a fair exchange: less duplicate licensing for foreign distributors, in return for clearer supplier visibility and genuine documented procedures. The amendments take effect on December 14, 2026, and the six-month run-up is meant for getting ready. Importers and distributors that reassess their licensing structure, build their supplier lists, and upgrade their procedures now will move into the new framework with confidence, while those who wait risk a scramble or a finding at their next inspection. The smart move is to treat this as a quality-system upgrade, not a paperwork chore.

Sources and References

Health Canada: Phase 2 of our work to modernize medical device establishment licensing (MDCP Bulletin, June 17, 2026)

Canada Gazette, Part II: Regulations Amending the Medical Devices Regulations (Establishment Licences), SOR/2026-110

Canada Gazette, Part I: pre-published amendments, November 8, 2025

Health Canada: Guidance on medical device establishment licensing (GUI-0016)

Health Canada: Forward Regulatory Plan 2026-2028